The efficacy and safety of bucillamine as a second-line DMARD in the treatment of rheumatoid arthritis: a retrospective cohort study

We investigated the efficacy and safety of bucillamine administered as a second-line DMARD compared to administration as a first-line DMARD in the treatment of rheumatoid arthritis (RA). We conducted a retrospective cohort study and reviewed medical records of 86 patients with active RA who began to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Modern rheumatology 2008, Vol.18 (6), p.609-614
Hauptverfasser:	Suda, Akiko, Nagaoka, Shouhei, Ohono, Shigeru, Ideguchi, Haruko, Soga, Takayoshi, Ishigatsubo, Yoshiaki
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - diagnosis Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - physiopathology Cohort Studies Comparative studies Cysteine - analogs & derivatives Cysteine - therapeutic use Drug therapy Female Health Status Humans Joints - drug effects Joints - physiopathology Male Medicine Medicine & Public Health Middle Aged Original Article Orthopedics Remission Induction Retrospective Studies Rheumatoid arthritis Rheumatology Severity of Illness Index Side effects Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!